ACTA1 and Hepatic fibrosis: Antagonism of S1P3 receptor through administration of CAY-10444 attenuates liver fibrosis by inhibiting BMMs migration and reducing α-SMA, procollagen and collagen I and III, TGF-β1 and hydroxyproline content in mice after BDL (Yang et al., 2015).